Results 231 to 240 of about 41,304 (260)
Some of the next articles are maybe not open access.
Direct oral anticoagulants today
Medicina Clínica (English Edition), 2021Carlos, Escobar Cervantes +1 more
openaire +2 more sources
Direct Oral Anticoagulants in Cancer Patients
Seminars in Thrombosis and Hemostasis, 2019AbstractCancer-associated thrombosis (CAT) is a common occurrence in the journey of a cancer patient and its management poses significant challenges. Low molecular weight heparin (LMWH) is the standard of care but the high cost and the inconvenience of daily injections have led to low persistence with therapy.
Deepa, Suryanarayan +2 more
openaire +2 more sources
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants
The Lancet HaematologyOver the last decade, the advent of direct oral anticoagulants (DOACs) has rapidly changed the landscape of anticoagulation. In the early 2010s, DOACs became widely available for stroke prevention in atrial fibrillation and the treatment of venous thromboembolism.
Ageno W. +4 more
openaire +3 more sources
2015
Direct oral anticoagulants (DOACs) are rapidly changing the way we think about selecting, treating, and monitoring patients in need of anticoagulation. These agents may be used for either treatment or prophylaxis of systemic embolism and have been compared to vitamin K antagonist (e.g., warfarin) for many of the same indications.
openaire +1 more source
Direct oral anticoagulants (DOACs) are rapidly changing the way we think about selecting, treating, and monitoring patients in need of anticoagulation. These agents may be used for either treatment or prophylaxis of systemic embolism and have been compared to vitamin K antagonist (e.g., warfarin) for many of the same indications.
openaire +1 more source
Reversal of direct oral anticoagulants
British Journal of Hospital Medicine, 2018Oliver, Cohen +2 more
openaire +2 more sources
Research and Practice in Thrombosis and Haemostasis, 2022
Pieter M De Kesel, Katrien M J Devreese
exaly
Pieter M De Kesel, Katrien M J Devreese
exaly
Potential Dexamethasone–Direct Oral Anticoagulant Drug Interaction: Is This a Concern in COVID?
Annals of Pharmacotherapy, 2022Qianyue Liu, Candice L Garwood
exaly
Direct oral anticoagulants and gastroenterologists
The Lancet Gastroenterology & Hepatology, 2017openaire +2 more sources
Reasons for Nonadherence to the Direct Oral Anticoagulant Apixaban
JACC: Advances, 2023Derjung M Tarn, Janice B Schwartz
exaly

